This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Leland Stanford Junior University. Active years: 2001-2002.
Company Filing History:
Years Active: 2001-2002
Title: Innovations by Chengbiao Wu
Introduction
Chengbiao Wu is a notable inventor based in San Jose, CA. He has made significant contributions to the field of neuroscience through his innovative research and patents. With a total of 2 patents, his work focuses on the use of GPR30 receptor ligands to mediate neurotrophic action.
Latest Patents
Wu's latest patents include methods for preventing or treating neurological dysfunction by administering ligands that activate the GPR30 receptor. These ligands, which include estrogens and structurally related molecules, are designed to be orally available drugs that can effectively cross into the brain from the bloodstream. His patents also provide screening methods for ligands that do not activate other estrogen receptors, thereby avoiding the classical estrogenic effects associated with these receptors.
Career Highlights
Chengbiao Wu is affiliated with Leland Stanford Junior University, where he continues to advance his research in neuroprotective agents. His work has the potential to lead to new therapeutic strategies for neurological disorders.
Collaborations
Wu has collaborated with esteemed colleagues such as Ronald J. Weigel and William C. Mobley, contributing to a rich environment of innovation and discovery.
Conclusion
Chengbiao Wu's contributions to the field of neuroscience through his patents and research are noteworthy. His innovative approaches to neurological dysfunction highlight the importance of ongoing research in this critical area.